Price Chart
Key Statistics
Previous Close
$32.44Day Range
52-Week Range
Avg Volume
20.6KDividend Yield
1.27%Expense Ratio
0.59%AUM
$62.3MShares Outstanding
1.3METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 43.15% |
| Denmark | 19.60% |
| China | 17.29% |
| Japan | 5.63% |
| South Korea | 3.55% |
| United Kingdom | 3.41% |
| Switzerland | 3.03% |
| Hong Kong | 2.85% |
| Singapore | 0.87% |
| Other | 0.64% |
Fund Information
- Issuer
- Roundhill Investments
- Category
- Healthcare
- Types
- Pharma
- Inception Date
- May 21, 2024
- Exchange
- NASDAQ
- Description
- Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.
Similar ETFs
The Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund issued by Roundhill Investments that launched on May 21, 2024. It currently manages $62.3M in assets under management. The fund charges an expense ratio of 0.59%. The fund holds 29 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 65.0% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 13.18% | 168,984 | $8.2M |
| 2 | LLY | Eli Lilly & Co | 12.64% | 6,606 | $7.9M |
| 3 | PFE | Pfizer Inc | 6.50% | 165,697 | $4.1M |
| 4 | 1093.HK | CSPC Pharmaceutical Group Ltd | 6.50% | 3,728,000 | $4.1M |
| 5 | VKTX | Viking Therapeutics Inc | 5.22% | 93,822 | $3.3M |
| 6 | KLRA | Kailera Therapeutics Inc | 4.99% | 176,239 | $3.1M |
| 7 | 4519.T | Chugai Pharmaceutical Co Ltd | 4.38% | 60,500 | $2.7M |
| 8 | AMGN | Amgen Inc | 3.99% | 6,634 | $2.5M |
| 9 | ZEAL.CO | Zealand Pharma A/S | 3.93% | 55,309 | $2.5M |
| 10 | 128940.KS | Hanmi Pharm Co Ltd | 3.64% | 8,509 | $2.3M |
| 11 | 1672.HK | Ascletis Pharma Inc | 3.57% | 1,943,000 | $2.2M |
| 12 | AZN | AstraZeneca PLC | 3.42% | 12,621 | $2.1M |
| 13 | ROP.SW | Roche Holding AG | 3.17% | 4,570 | $2.0M |
| 14 | MBX | MBX Biosciences Inc | 3.14% | 31,685 | $2.0M |
| 15 | 3933.HK | United Laboratories International Holdings Ltd/The | 2.83% | 1,524,000 | $1.8M |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | +0.27% | |
| 1W | +1.04% | |
| 1M | -0.65% | |
| 3M | +6.26% | |
| 6M | -9.93% | |
| YTD | -5.28% | |
| 1Y | +22.38% | |
| 3Y | +28.20% | |
| 5Y | +28.20% |
Moving Averages
$32.78
Below 20-Day MA$31.60
Above 50-Day MA$32.08
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$37.01
Current Price
$32.52
52-Week Low
$23.47
Current Yield
1.27%
Annual Dividend
$0.8729
Frequency
1x/year
Last Ex-Date
Dec 30, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 30, 2025 | $0.4099 | Dec 31, 2025 |
| Dec 30, 2025 | $0.4099 | Dec 31, 2025 |
| Dec 30, 2024 | $0.0531 | Dec 31, 2024 |
Dividend Payments Over Time
Category Comparison
| Metric | OZEM | Healthcare(212 ETFs) | Pharma(29 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.59% | 0.62% | 0.66% |
| AUM | $62.3M | $1.86B | $1.62B |
| Dividend Yield | 1.27% | 3.66% | 1.82% |
| Avg Volume | 20.6K | 445.6K | 519.0K |
| Holdings | 29 | 147 | 39 |
| Performance | |||
| 1-Month Return | +1.84% | -0.85% | +1.56% |
| 6-Month Return | +3.53% | +12.94% | +17.68% |
| YTD Return | -5.04% | +9.31% | +13.93% |
| 1-Year Return | +10.00% | +14.67% | +27.83% |
Compare with Another ETF
Search for an ETF to compare with OZEM:
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.